查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2112524

近紅外線成像市場：市場規模和佔有率分析—趨勢、成長要素、競爭格局和預測（2026-2032 年）

Near-Infrared Imaging Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2026 - 2032)
出版日期: | 出版商: Prescient & Strategic Intelligence | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025年全球近紅外線成像市場規模為23億美元，預計2032年將達33億美元，2026年至2032年的複合年成長率（CAGR）為5.1%。這一成長主要得益於醫療保健系統向微創診斷和手術技術的轉變。近紅外線成像技術使臨床醫生能夠在手術過程中即時觀察組織、血管和灌注模式。

心血管疾病的沉重負擔是造成這種需求的主要原因。根據健康指標與評估研究所 (IHME) 預測，2023 年心血管疾病將導致全球整體1,920 萬人死亡。如此嚴峻的情況迫使臨床醫師在手術過程中依賴影像工具來評估灌注和血管顯露。

此外，影像感測器、螢光劑和行動裝置的設計不斷進步，也推動了這個市場的發展。這些進步促進了近紅外線系統在醫院手術室、實驗室和新興醫療機構的應用。

關鍵見解

該產品以約5.3%的複合年成長率和60%的市場佔有率，成為規模最大且成長最快的產品類型類別。這是因為診斷影像依賴在手術定位和診斷影像中反覆使用造影劑。根據美國癌症研究協會（AACR）估計，到2025年，全球預計將新增2,000萬例癌症病例，將推動對顯影劑的強勁需求。

腫瘤學是該技術應用範圍最廣、成長最快的領域，市佔率達35%，年複合成長率約5.7%。這是因為該技術能夠幫助臨床醫生識別惡性組織並評估手術切緣。根據健康指標與評估研究所（IHME）預測，2023年全球新增癌症病例（不包括非黑色素瘤皮膚癌）將達1,850萬例。

醫院和診所手術量大，診斷影像基礎設施先進，是規模最大、成長最快的終端用戶群體，佔市場佔有率的 40%，複合年成長率約為 5.5%。

北美地區佔最大的區域市場佔有率，達40%，這得益於該地區早期對先進影像技術的應用以及健全的保險報銷體系。根據美國癌症協會預測，2024年美國將新增超過200萬例癌症病例，先進影像技術的需求將持續旺盛。

亞太地區複合年成長率最高，約 6.0%，中國、印度、日本和韓國等國家的醫院正在擴大其對先進診斷和外科技術的獲取途徑，而這些技術的採用率此前相對較低。

日本憑藉其老齡化人口和對精準醫療的重視，在區域內確立了強大的地位。到2024年，日本65歲及以上人口將達到3,619萬，這將推動對用於治療與老齡化相關的複雜外科疾病的精準成像工具的需求。

在印度，隨著私立醫院不斷提升其先進的外科手術能力，螢光引導影像技術的應用正逐漸普及。根據印度旅遊部統計，預計到2024年將有644,387名外國遊客因醫療目的前往印度，這將推動對配備螢光引導成像技術的國際認證醫院的投資。

與手術導引系統整合是關鍵趨勢，因為它使外科醫生能夠透過即時視覺化更精確地評估組織灌注情況。根據國際機器人聯盟（IFR）預測，2024年全球整體醫療機器人銷售成長91%，達到約16,700台，而同年手術機器人需求成長41%。

對微創手術日益成長的需求仍然是最大的驅動力。根據全球捐贈與移植觀察站（Global Donation and 人工林 Observatory）的數據，2024年全球將進行173,727例器官移植手術。此外，根據國際美容整形外科學會（International Society of Aesthetic Plastic Surgery）的數據，2023年全球將進行1,910萬例非手術美容計畫。

對於規模小規模的醫院和農村醫療機構而言，設備高成本和資源有限是主要阻礙因素。世界銀行預測，到2024年，全球將有34.551041億人生活在農村地區，凸顯了醫療服務不足地區規模龐大，這些地區缺乏足夠的資金來建設先進的影像基礎設施。

手術中の可視化における画像診断技術の活用拡大は、明確なビジネスチャンスとなっています。Olympus Corporationは2026年、フル4K解像度での螢光ガイド手術機能を備えた手術用画像診断プラットフォーム「VISERA ELITE III」を発売しました。現在、米国を含む世界各国で大腸,婦人科手術、および肝膵胆道系移植手術において利用されています。

成像系統、試劑和整合式視覺化軟體供應商之間的競爭格局仍然分散，人工智慧影像分析和與機器人輔助平台的兼容性是差異化的關鍵促進因素。徠卡顯微系統公司近期推出的Viventis SCAPE光片顯微鏡是其「聚焦顯微鏡」計畫的一部分，該計畫將於2026年啟動，屆時將透過徠卡及其授權合作夥伴在全球銷售。

目錄

第1章：調查範圍

第2章：調查方法

第3章摘要整理

第4章 市場指標

第5章 產業展望

  • 產業背景
  • 市場動態
  • 社會政治影響
  • 波特五力分析
  • 生命週期分析
  • 創新與科技趨勢
  • 經濟和監管影響
  • 打入市場策略

第6章 競爭情勢

  • 參與企業清單及其提供的服務
  • 主要公司市佔率（2025 年）
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 主要公司的競爭標竿分析
  • 主要公司的產品基準
  • 主要參與企業近期策略趨勢
  • 企業領導矩陣

第7章：全球市場

  • 概述
  • 按產品分類的市場收入（2021-2032 年）
  • 依適應症分類的市場收入（2021-2032 年）
  • 按最終用戶分類的市場收入（2021-2032 年）
  • 區域市場收入（2021-2032 年）

第8章：北美市場

第9章：歐洲市場

第10章：亞太市場

第11章：拉丁美洲市場

第12章：中東和非洲市場

第13章：美國市場

第14章：加拿大市場

第15章：德國市場

第16章英國市場

第17章：法國市場

第18章：義大利市場

第19章：西班牙市場

第20章：中國市場

第21章：印度市場

第22章：日本市場

第23章：韓國市場

第24章：澳洲市場

第25章：巴西市場

第26章：墨西哥市場

第27章：沙烏地阿拉伯市場

第28章：南非市場

第29章 阿拉伯聯合大公國市場

第30章：公司簡介

第31章附錄

簡介目錄
Product Code: 14054

The global near-infrared imaging market was valued at USD 2.3 billion in 2025 and is projected to reach USD 3.3 billion by 2032, growing at a CAGR of 5.1% between 2026 and 2032. Growth is being driven by healthcare systems moving toward less invasive diagnostic and surgical techniques, as near-infrared imaging lets clinicians view tissues, blood vessels, and perfusion patterns in real time during procedures.

Cardiovascular disease burden underscores much of this demand. Cardiovascular disease deaths reached 19.2 million globally in 2023, according to the Institute for Health Metrics and Evaluation, a scale that keeps clinicians reliant on imaging tools that can evaluate perfusion and vessel visibility during procedures.

The market is also benefiting from steady improvements in imaging sensors, fluorescent agents, and portable device design, which are making near-infrared systems easier to integrate into operating rooms across hospitals, research laboratories, and emerging healthcare settings.

Key Insights

Reagents are both the largest and fastest-growing product category, at 60% share and approximately 5.3% CAGR, since imaging depends on repeated contrast agent use during surgical mapping and diagnostic imaging; an estimated 20 million new cancer cases occurred globally in 2025, according to the American Association for Cancer Research, sustaining steady reagent consumption.

Oncology is both the largest and fastest-growing indication, at 35% share and approximately 5.7% CAGR, as the technology helps clinicians distinguish malignant tissue and assess surgical margins; global cancer incidence reached 18.5 million new cases in 2023, excluding non-melanoma skin cancers, according to the Institute for Health Metrics and Evaluation.

Hospitals and Clinics are both the largest and fastest-growing end-user segment, at 40% share and approximately 5.5% CAGR, given high procedure volumes and access to advanced imaging infrastructure.

North America holds the largest regional share, at 40%, backed by early adoption of advanced imaging technologies and strong reimbursement systems. The U.S. saw over 2.0 million new cancer cases diagnosed in 2024, according to the American Cancer Society, sustaining continuous demand for advanced diagnostic imaging.

Asia-Pacific posts the highest regional CAGR, at approximately 6.0%, as hospitals across China, India, Japan, and South Korea expand access to advanced diagnostic and surgical technologies from a comparatively lower adoption base.

Japan holds a strong regional position given its aging population and precision healthcare focus; the population aged 65 and older reached 36.19 million in 2024, driving demand for precision imaging tools in complex, age-related surgical conditions.

India is seeing increasing adoption as private hospitals expand advanced surgical capabilities; 644,387 foreign tourists visited India for medical treatment in 2024, according to the Ministry of Tourism, supporting investment in internationally accredited hospitals with fluorescence-guided imaging.

Integration with surgical navigation systems is a defining trend, as real-time visualization lets surgeons evaluate tissue perfusion with greater precision. Sales of medical robots increased 91% to around 16,700 units globally in 2024, according to the International Federation of Robotics, while demand for surgical robots rose 41% the same year.

Rising demand for minimally invasive procedures remains the biggest driver. 173,727 organ transplants were performed globally in 2024, according to the Global Observatory on Donation and Transplantation, while 19.1 million non-surgical aesthetic procedures were performed worldwide in 2023, per the International Society of Aesthetic Plastic Surgery.

High equipment costs and limited accessibility are the main restraint, particularly for smaller hospitals and rural facilities; 3,455,100,410 people lived in rural areas globally in 2024, according to the World Bank, underscoring the scale of underserved settings that lack capital budgets for advanced imaging infrastructure.

Expansion of imaging use in surgical visualization presents a clear opportunity. Olympus Corporation launched its VISERA ELITE III surgical imaging platform in 2026 with fluorescence-guided surgery capabilities in full 4K, now available globally including in the United States across colorectal, gynecological, and hepatopancreatobiliary transplant surgery.

The competitive landscape remains fragmented across companies offering imaging systems, reagents, and integrated visualization software, differentiating through AI-enabled image analysis and compatibility with robotic-assisted platforms. Recent activity includes Leica Microsystems' 2026 introduction of the Viventis SCAPE light sheet microscope at Focus on Microscopy, made available globally through the company and its authorized partners.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market Size Breakdown, by Product
    • 1.4.2. Market Size Breakdown, by Indication
    • 1.4.3. Market Size Breakdown, by End User
    • 1.4.4. Market Size Breakdown, by Region
    • 1.4.5. Market Size Breakdown, by Country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Revenue
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence Database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Industry Background
  • 5.2. Market Dynamics
    • 5.2.1. Trends
    • 5.2.2. Drivers
    • 5.2.3. Restraints/Challenges
    • 5.2.4. Emerging Economies and Key Opportunities
    • 5.2.5. Impact Analysis of Drivers/Restraints
  • 5.3. Sociopolitical Impact
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Bargaining Power of Buyers
    • 5.4.2. Bargaining Power of Suppliers
    • 5.4.3. Threat of New Entrants
    • 5.4.4. Intensity of Rivalry
    • 5.4.5. Threat of Substitutes
  • 5.5. Lifecycle Analysis
  • 5.6. Innovation and Technology Trends
  • 5.7. Economic and Regulatory Impact
  • 5.8. Market Entry Strategies

Chapter 6. Competitive Landscape

  • 6.1. List of Market Players and their Offerings
  • 6.2. Market Share of Key Players (2025)
    • 6.2.1. Global
    • 6.2.2. North America
    • 6.2.3. Europe
    • 6.2.4. Asia-Pacific
    • 6.2.5. Latin America
    • 6.2.6. Middle East and Africa
  • 6.3. Competitive Benchmarking of Key Players
  • 6.4. Product Benchmarking of Key Players
  • 6.5. Recent Strategic Developments by Key Players
  • 6.6. Company Leadership Matrix

Chapter 7. Global Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Product (2021-2032)
  • 7.3. Market Revenue, by Indication (2021-2032)
  • 7.4. Market Revenue, by End User (2021-2032)
  • 7.5. Market Revenue, by Region (2021-2032)

Chapter 8. North America Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Product (2021-2032)
  • 8.3. Market Revenue, by Indication (2021-2032)
  • 8.4. Market Revenue, by End User (2021-2032)
  • 8.5. Market Revenue, by Country (2021-2032)

Chapter 9. Europe Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Product (2021-2032)
  • 9.3. Market Revenue, by Indication (2021-2032)
  • 9.4. Market Revenue, by End User (2021-2032)
  • 9.5. Market Revenue, by Country (2021-2032)

Chapter 10. Asia-Pacific Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Product (2021-2032)
  • 10.3. Market Revenue, by Indication (2021-2032)
  • 10.4. Market Revenue, by End User (2021-2032)
  • 10.5. Market Revenue, by Country (2021-2032)

Chapter 11. Latin America Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Product (2021-2032)
  • 11.3. Market Revenue, by Indication (2021-2032)
  • 11.4. Market Revenue, by End User (2021-2032)
  • 11.5. Market Revenue, by Country (2021-2032)

Chapter 12. Middle East and Africa Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Product (2021-2032)
  • 12.3. Market Revenue, by Indication (2021-2032)
  • 12.4. Market Revenue, by End User (2021-2032)
  • 12.5. Market Revenue, by Country (2021-2032)

Chapter 13. U.S. Market

  • 13.1. Overview
  • 13.2. Economic Indicators
  • 13.3. Demographics and Population Insights
  • 13.4. Growth Drivers
  • 13.5. Challenges and Barriers
  • 13.6. Competitive Strategies
  • 13.7. Emerging Players
  • 13.8. Market Size and Forecast
    • 13.8.1. Market Revenue, by Product (2021-2032)
    • 13.8.2. Market Revenue, by Indication (2021-2032)
    • 13.8.3. Market Revenue, by End User (2021-2032)

Chapter 14. Canada Market

  • 14.1. Overview
  • 14.2. Economic Indicators
  • 14.3. Demographics and Population Insights
  • 14.4. Growth Drivers
  • 14.5. Challenges and Barriers
  • 14.6. Competitive Strategies
  • 14.7. Emerging Players
  • 14.8. Market Size and Forecast
    • 14.8.1. Market Revenue, by Product (2021-2032)
    • 14.8.2. Market Revenue, by Indication (2021-2032)
    • 14.8.3. Market Revenue, by End User (2021-2032)

Chapter 15. Germany Market

  • 15.1. Overview
  • 15.2. Economic Indicators
  • 15.3. Demographics and Population Insights
  • 15.4. Growth Drivers
  • 15.5. Challenges and Barriers
  • 15.6. Competitive Strategies
  • 15.7. Emerging Players
  • 15.8. Market Size and Forecast
    • 15.8.1. Market Revenue, by Product (2021-2032)
    • 15.8.2. Market Revenue, by Indication (2021-2032)
    • 15.8.3. Market Revenue, by End User (2021-2032)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Economic Indicators
  • 16.3. Demographics and Population Insights
  • 16.4. Growth Drivers
  • 16.5. Challenges and Barriers
  • 16.6. Competitive Strategies
  • 16.7. Emerging Players
  • 16.8. Market Size and Forecast
    • 16.8.1. Market Revenue, by Product (2021-2032)
    • 16.8.2. Market Revenue, by Indication (2021-2032)
    • 16.8.3. Market Revenue, by End User (2021-2032)

Chapter 17. France Market

  • 17.1. Overview
  • 17.2. Economic Indicators
  • 17.3. Demographics and Population Insights
  • 17.4. Growth Drivers
  • 17.5. Challenges and Barriers
  • 17.6. Competitive Strategies
  • 17.7. Emerging Players
  • 17.8. Market Size and Forecast
    • 17.8.1. Market Revenue, by Product (2021-2032)
    • 17.8.2. Market Revenue, by Indication (2021-2032)
    • 17.8.3. Market Revenue, by End User (2021-2032)

Chapter 18. Italy Market

  • 18.1. Overview
  • 18.2. Economic Indicators
  • 18.3. Demographics and Population Insights
  • 18.4. Growth Drivers
  • 18.5. Challenges and Barriers
  • 18.6. Competitive Strategies
  • 18.7. Emerging Players
  • 18.8. Market Size and Forecast
    • 18.8.1. Market Revenue, by Product (2021-2032)
    • 18.8.2. Market Revenue, by Indication (2021-2032)
    • 18.8.3. Market Revenue, by End User (2021-2032)

Chapter 19. Spain Market

  • 19.1. Overview
  • 19.2. Economic Indicators
  • 19.3. Demographics and Population Insights
  • 19.4. Growth Drivers
  • 19.5. Challenges and Barriers
  • 19.6. Competitive Strategies
  • 19.7. Emerging Players
  • 19.8. Market Size and Forecast
    • 19.8.1. Market Revenue, by Product (2021-2032)
    • 19.8.2. Market Revenue, by Indication (2021-2032)
    • 19.8.3. Market Revenue, by End User (2021-2032)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Economic Indicators
  • 20.3. Demographics and Population Insights
  • 20.4. Growth Drivers
  • 20.5. Challenges and Barriers
  • 20.6. Competitive Strategies
  • 20.7. Emerging Players
  • 20.8. Market Size and Forecast
    • 20.8.1. Market Revenue, by Product (2021-2032)
    • 20.8.2. Market Revenue, by Indication (2021-2032)
    • 20.8.3. Market Revenue, by End User (2021-2032)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Economic Indicators
  • 21.3. Demographics and Population Insights
  • 21.4. Growth Drivers
  • 21.5. Challenges and Barriers
  • 21.6. Competitive Strategies
  • 21.7. Emerging Players
  • 21.8. Market Size and Forecast
    • 21.8.1. Market Revenue, by Product (2021-2032)
    • 21.8.2. Market Revenue, by Indication (2021-2032)
    • 21.8.3. Market Revenue, by End User (2021-2032)

Chapter 22. Japan Market

  • 22.1. Overview
  • 22.2. Economic Indicators
  • 22.3. Demographics and Population Insights
  • 22.4. Growth Drivers
  • 22.5. Challenges and Barriers
  • 22.6. Competitive Strategies
  • 22.7. Emerging Players
  • 22.8. Market Size and Forecast
    • 22.8.1. Market Revenue, by Product (2021-2032)
    • 22.8.2. Market Revenue, by Indication (2021-2032)
    • 22.8.3. Market Revenue, by End User (2021-2032)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Economic Indicators
  • 23.3. Demographics and Population Insights
  • 23.4. Growth Drivers
  • 23.5. Challenges and Barriers
  • 23.6. Competitive Strategies
  • 23.7. Emerging Players
  • 23.8. Market Size and Forecast
    • 23.8.1. Market Revenue, by Product (2021-2032)
    • 23.8.2. Market Revenue, by Indication (2021-2032)
    • 23.8.3. Market Revenue, by End User (2021-2032)

Chapter 24. Australia Market

  • 24.1. Overview
  • 24.2. Economic Indicators
  • 24.3. Demographics and Population Insights
  • 24.4. Growth Drivers
  • 24.5. Challenges and Barriers
  • 24.6. Competitive Strategies
  • 24.7. Emerging Players
  • 24.8. Market Size and Forecast
    • 24.8.1. Market Revenue, by Product (2021-2032)
    • 24.8.2. Market Revenue, by Indication (2021-2032)
    • 24.8.3. Market Revenue, by End User (2021-2032)

Chapter 25. Brazil Market

  • 25.1. Overview
  • 25.2. Economic Indicators
  • 25.3. Demographics and Population Insights
  • 25.4. Growth Drivers
  • 25.5. Challenges and Barriers
  • 25.6. Competitive Strategies
  • 25.7. Emerging Players
  • 25.8. Market Size and Forecast
    • 25.8.1. Market Revenue, by Product (2021-2032)
    • 25.8.2. Market Revenue, by Indication (2021-2032)
    • 25.8.3. Market Revenue, by End User (2021-2032)

Chapter 26. Mexico Market

  • 26.1. Overview
  • 26.2. Economic Indicators
  • 26.3. Demographics and Population Insights
  • 26.4. Growth Drivers
  • 26.5. Challenges and Barriers
  • 26.6. Competitive Strategies
  • 26.7. Emerging Players
  • 26.8. Market Size and Forecast
    • 26.8.1. Market Revenue, by Product (2021-2032)
    • 26.8.2. Market Revenue, by Indication (2021-2032)
    • 26.8.3. Market Revenue, by End User (2021-2032)

Chapter 27. Saudi Arabia Market

  • 27.1. Overview
  • 27.2. Economic Indicators
  • 27.3. Demographics and Population Insights
  • 27.4. Growth Drivers
  • 27.5. Challenges and Barriers
  • 27.6. Competitive Strategies
  • 27.7. Emerging Players
  • 27.8. Market Size and Forecast
    • 27.8.1. Market Revenue, by Product (2021-2032)
    • 27.8.2. Market Revenue, by Indication (2021-2032)
    • 27.8.3. Market Revenue, by End User (2021-2032)

Chapter 28. South Africa Market

  • 28.1. Overview
  • 28.2. Economic Indicators
  • 28.3. Demographics and Population Insights
  • 28.4. Growth Drivers
  • 28.5. Challenges and Barriers
  • 28.6. Competitive Strategies
  • 28.7. Emerging Players
  • 28.8. Market Size and Forecast
    • 28.8.1. Market Revenue, by Product (2021-2032)
    • 28.8.2. Market Revenue, by Indication (2021-2032)
    • 28.8.3. Market Revenue, by End User (2021-2032)

Chapter 29. U.A.E. Market

  • 29.1. Overview
  • 29.2. Economic Indicators
  • 29.3. Demographics and Population Insights
  • 29.4. Growth Drivers
  • 29.5. Challenges and Barriers
  • 29.6. Competitive Strategies
  • 29.7. Emerging Players
  • 29.8. Market Size and Forecast
    • 29.8.1. Market Revenue, by Product (2021-2032)
    • 29.8.2. Market Revenue, by Indication (2021-2032)
    • 29.8.3. Market Revenue, by End User (2021-2032)

Chapter 30. Company Profiles

Chapter 31. Appendix

  • 31.1. Sources and References
  • 31.2. Related Reports